BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18976637)

  • 21. Specific inhibition of caspase-8 and -9 in CHO cells enhances cell viability in batch and fed-batch cultures.
    Yun CY; Liu S; Lim SF; Wang T; Chung BY; Jiat Teo J; Chuan KH; Soon AS; Goh KS; Song Z
    Metab Eng; 2007; 9(5-6):406-18. PubMed ID: 17658284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors.
    Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG
    Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and catalytic properties of human caspase family members.
    Garcia-Calvo M; Peterson EP; Rasper DM; Vaillancourt JP; Zamboni R; Nicholson DW; Thornberry NA
    Cell Death Differ; 1999 Apr; 6(4):362-9. PubMed ID: 10381624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and characterization of constitutively active human caspase-14.
    Park K; Kuechle MK; Choe Y; Craik CS; Lawrence OT; Presland RB
    Biochem Biophys Res Commun; 2006 Sep; 347(4):941-8. PubMed ID: 16854378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase structure, proteolytic substrates, and function during apoptotic cell death.
    Nicholson DW
    Cell Death Differ; 1999 Nov; 6(11):1028-42. PubMed ID: 10578171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis.
    Becker JW; Rotonda J; Soisson SM; Aspiotis R; Bayly C; Francoeur S; Gallant M; Garcia-Calvo M; Giroux A; Grimm E; Han Y; McKay D; Nicholson DW; Peterson E; Renaud J; Roy S; Thornberry N; Zamboni R
    J Med Chem; 2004 May; 47(10):2466-74. PubMed ID: 15115390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-DEVD-N'-morpholinecarbonyl-rhodamine 110: novel caspase-3 fluorogenic substrates for cell-based apoptosis assay.
    Wang ZQ; Liao J; Diwu Z
    Bioorg Med Chem Lett; 2005 May; 15(9):2335-8. PubMed ID: 15837320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using peptidic inhibitors to systematically probe the S1' site of caspase-3 and caspase-7.
    Goode DR; Sharma AK; Hergenrother PJ
    Org Lett; 2005 Aug; 7(16):3529-32. PubMed ID: 16048334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of caspase activity during apoptosis in pubertal rat spermatogenesis.
    Codelia VA; Cisternas P; Moreno RD
    Mol Reprod Dev; 2008 May; 75(5):881-9. PubMed ID: 17926353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of a potent and selective peptidomimetic inhibitor of caspase-3.
    Micale N; Vairagoundar R; Yakovlev AG; Kozikowski AP
    J Med Chem; 2004 Dec; 47(26):6455-8. PubMed ID: 15588079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cascleave: towards more accurate prediction of caspase substrate cleavage sites.
    Song J; Tan H; Shen H; Mahmood K; Boyd SE; Webb GI; Akutsu T; Whisstock JC
    Bioinformatics; 2010 Mar; 26(6):752-60. PubMed ID: 20130033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of caspase cleavage-site phosphorylation on proteolysis.
    Tözsér J; Bagossi P; Zahuczky G; Specht SI; Majerova E; Copeland TD
    Biochem J; 2003 May; 372(Pt 1):137-43. PubMed ID: 12589706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and substrate specificity of caspase-14.
    Mikolajczyk J; Scott FL; Krajewski S; Sutherlin DP; Salvesen GS
    Biochemistry; 2004 Aug; 43(32):10560-9. PubMed ID: 15301553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian initiator apoptotic caspases.
    Ho PK; Hawkins CJ
    FEBS J; 2005 Nov; 272(21):5436-53. PubMed ID: 16262685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspases - an update.
    Chowdhury I; Tharakan B; Bhat GK
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Sep; 151(1):10-27. PubMed ID: 18602321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors.
    Maillard MC; Brookfield FA; Courtney SM; Eustache FM; Gemkow MJ; Handel RK; Johnson LC; Johnson PD; Kerry MA; Krieger F; Meniconi M; Muñoz-Sanjuán I; Palfrey JJ; Park H; Schaertl S; Taylor MG; Weddell D; Dominguez C
    Bioorg Med Chem; 2011 Oct; 19(19):5833-51. PubMed ID: 21903398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The yeast three-hybrid system as a tool to study caspases.
    van Criekinge W; Schotte P; Heyninck K; Beyaert R
    Methods Mol Biol; 2004; 282():243-54. PubMed ID: 15105569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 131I-labeled peptides as caspase substrates for apoptosis imaging.
    Bauer C; Bauder-Wuest U; Mier W; Haberkorn U; Eisenhut M
    J Nucl Med; 2005 Jun; 46(6):1066-74. PubMed ID: 15937321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General in vitro caspase assay procedures.
    Boucher D; Duclos C; Denault JB
    Methods Mol Biol; 2014; 1133():3-39. PubMed ID: 24567092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site.
    Kuzelová K; Grebenová D; Hrkal Z
    Cytometry A; 2007 Aug; 71(8):605-11. PubMed ID: 17549763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.